Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Kibo invests in Eqtec project; Clinigen falls

Thu, 16th Sep 2021 10:55

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Galileo Resources PLC, up 20% at 1.32 pence, 12-month range 0.61p-2.80p. The miner, with projects in Botswana, Zambia and South Africa, says all conditions for licence sale agreement with ASX-listed Sandfire Resources Ltd have been met. Completion of deal set for September 22. The deal, first announced in January, will see Sandfire pay USD1.5 million in cash for nine Kalahari copper belt licences.

----------

Kibo Energy PLC, up 16% at 0.26 pence, 12-month range 0.16p-0.56p. The Africa- and UK-focused energy company will acquire just under a 55% stake in the proposed Billingham waste gasification and power plant in Teesside, UK. Fellow AIM listing Eqtec PLC will retain just under over a 45% stake. Kibo's initial funding contribution will amount to GBP3 million. Eqtec shares were 2.4% lower.

----------

AIM - LOSERS

----------

Clinigen Group PLC, down 9.7% at 632.14 pence, 12-month range 554.00p-891.79p. Staffordshire-based pharmaceuticals and services provider lowers its earnings before interest, tax, depreciation and amortisation growth outlook for the new financial year. It now expects Ebitda growth between 5% and 10%. Clinigen anticipates lower sales of the Erwinase cancer treatment. Double-digit growth was previously expected. In the year ended June 30, revenue rose 12% to GBP523.6 million from GBP466.7 million. Pretax profit more than doubled to GBP51.8 million from GBP23.2 million.

----------

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
8 Dec 2021 08:16

Clinigen to be taken private by Triton in £1.2bn deal, shares surge

(Sharecast News) - Clinigen surged on Wednesday after agreeing to be taken private by European investment firm Triton in a £1.2bn deal.

Read more
2 Dec 2021 14:28

Shares in Clinigen surge on takeover talks with Triton Investment

Shares in Clinigen surge on takeover talks with Triton Investment

Read more
2 Dec 2021 12:59

Clinigen confirms takeover talks with Triton, shares surge

(Sharecast News) - Clinigen shares surged on Thursday after the company confirmed it has received a non-binding indicative proposal from investment firm Triton about a possible offer.

Read more
2 Dec 2021 09:52

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

LONDON BROKER RATINGS: Upgrades for Old Mutual and Superdry; Drax cut

Read more
1 Dec 2021 13:42

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Clinigen's leukaemia treatment Erwinase fails to gain approval in US

Read more
29 Nov 2021 11:21

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Clinigen signs exclusive agreement with Nippon Shinyaku on Viltepso

Read more
25 Nov 2021 16:01

UK dividends calendar - next 7 days

UK dividends calendar - next 7 days

Read more
17 Nov 2021 16:01

UK shareholder meetings calendar - next 7 days

UK shareholder meetings calendar - next 7 days

Read more
5 Nov 2021 09:55

Liberum lowers target price on Clinigen

(Sharecast News) - Analysts at Liberum lowered their target price on pharmaceutical services and products group Clinigen from 886.0p to 800.0p on Friday but stated risks still appeared to be "skewed to the upside".

Read more
8 Oct 2021 08:46

Clinigen and Humanigen partner to progress investigational Covid drug

Clinigen and Humanigen partner to progress investigational Covid drug

Read more
22 Sep 2021 19:31

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

TRADING UPDATES: Clinigen signs Copiktra deal; Alien "really pleased"

Read more
22 Sep 2021 13:34

Clinigen to distribute 'Copiktra' in most of Europe

(Sharecast News) - Pharmaceutical products and services provider Clinigen has signed an exclusive agreement with Secura Bio for the supply and distribution of 'Copiktra' in most of Europe, it announced on Wednesday.

Read more
16 Sep 2021 12:29

Clinigen cuts full-year earnings forecasts, shares fall

(Sharecast News) - Shares in Clinigen Group fell on Thursday after the pharmaceuticals specialist cut its full-year earnings forecast.

Read more
16 Sep 2021 12:07

Clinigen shares fall on lowered outlook as profit more than doubles

Clinigen shares fall on lowered outlook as profit more than doubles

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.